Citations (65)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
Liv Sagatun, Reidar Fossmark, Constantin S. Jianu, Gunnar Qvigstad, Ivar S. Nordrum, Patricia Mjønes & Helge L. Waldum. (2016) Follow-up of patients with ECL cell-derived tumours. Scandinavian Journal of Gastroenterology 51:11, pages 1398-1405.
Read now
Read now
Liv Sagatun, Constantin S Jianu, Reidar Fossmark, Ronald Mårvik, Ivar S Nordrum & Helge L Waldum. (2014) The gastric mucosa 25 years after proximal gastric vagotomy. Scandinavian Journal of Gastroenterology 49:10, pages 1173-1180.
Read now
Read now
Constantin S. Jianu, Reidar Fossmark, Unni Syversen, Øyvind Hauso, Vidar Fykse & Helge L. Waldum. (2011) Five-year follow-up of patients treated for 1 year with octreotide long-acting release for enterochromaffin-like cell carcinoids. Scandinavian Journal of Gastroenterology 46:4, pages 456-463.
Read now
Read now
Vidar Fykse, Arne Kristian Sandvik & Helge Lyder Waldum. (2005) One-year follow-up study of patients with enterochromaffin-like cell carcinoids after treatment with octreotide long-acting release. Scandinavian Journal of Gastroenterology 40:11, pages 1269-1274.
Read now
Read now
V. Fykse, A. K. Sandvik, G. Qvigstad, S. E. Falkmer, U. Syversen & H. L. Waldum. (2004) Treatment of ECL cell carcinoids with octreotide LAR. Scandinavian Journal of Gastroenterology 39:7, pages 621-628.
Read now
Read now
Irvin M Modlin, Mark Kidd & Kevin D. Lye. (2002) Biology and management of gastric carcinoid tumours: A review. The European Journal of Surgery 168:12, pages 669-683.
Read now
Read now
A. KOKKOLA, S.-M. SJÖBLOM, R. HAAPIAINEN, P. SIPPONEN, P. PUOLAKKAINEN, H. JÄRVINEN. (1998) The Risk of Gastric Carcinoma and Carcinoid Tumours in Patients with Pernicious Anaemia: A Prospective Follow-Up Study. Scandinavian Journal of Gastroenterology 33:1, pages 88-92.
Read now
Read now
Articles from other publishers (58)
Julio C. Poveda, Satyapal Chahar, Monica T. Garcia-Buitrago, Elizabeth A. Montgomery & Oliver G. McDonald. (2023) The Morphologic Spectrum of Gastric Type 1 Enterochromaffin–Like Cell Neuroendocrine Tumors. Modern Pathology 36:4, pages 100098.
Crossref
Crossref
Mushal Noor, Aaron R Huber, Justin M M Cates & Raul S Gonzalez. (2021) Risk factors for progression of appendiceal neuroendocrine tumours: low‐stage tumours <5 mm appear to be overwhelmingly indolent and may merit a separate designation. Histopathology 79:3, pages 416-426.
Crossref
Crossref
A. V. Belkovets & N. V. Ozhiganova. (2021) Are all the polyps in the stomach the same?. Experimental and Clinical Gastroenterology 1:6, pages 134-139.
Crossref
Crossref
Antonia Ebert, Jochem König, Lara Frommer, Detlef Schuppan & George J Kahaly. (2020) Chromogranin Serves as Novel Biomarker of Endocrine and Gastric Autoimmunity. The Journal of Clinical Endocrinology & Metabolism 105:8, pages 2606-2615.
Crossref
Crossref
Fredy Nehme, Kyle Rowe, William Palko, Nathan Tofteland & William Salyers. (2019) Autoimmune metaplastic atrophic gastritis and association with neuroendocrine tumors of the stomach. Clinical Journal of Gastroenterology 13:3, pages 299-307.
Crossref
Crossref
Hendrik Rathke, Tim Holland-Letz, Walter Mier, Paul Flechsig, Eleni Mavriopoulou, Manuel Röhrich, Klaus Kopka, Markus Hohenfellner, Frederik Lars Giesel, Uwe Haberkorn & Clemens Kratochwil. (2020)
Response Prediction of
177
Lu-PSMA-617 Radioligand Therapy Using Prostate-Specific Antigen, Chromogranin A, and Lactate Dehydrogenase
. Journal of Nuclear Medicine 61:5, pages 689-695.
Crossref
Crossref
Mila Dimitrova Kovacheva-Slavova, Todor Asenov Angelov, Hristo Yankov Valkov, Hristo Ilianov Iliev & Borislav Georgiev Vladimirov. 2019. Gastritis - New Approaches and Treatments. Gastritis - New Approaches and Treatments.
Lingaku Lee, Irene Ramos-Alvarez, Tetsuhide Ito & Robert T. Jensen. (2019) Insights into Effects/Risks of Chronic Hypergastrinemia and Lifelong PPI Treatment in Man Based on Studies of Patients with Zollinger–Ellison Syndrome. International Journal of Molecular Sciences 20:20, pages 5128.
Crossref
Crossref
Kosmas Daskalakis, Marina Tsoli, Angeliki Karapanagioti, Maria Chrysochoou, Dimitrios Thomas, Stavros Sougioultzis, Ioannis Karoumpalis, Gregory A. Kaltsas & Krystallenia I. Alexandraki. (2019) Recurrence and metastatic potential in Type 1 gastric neuroendocrine neoplasms. Clinical Endocrinology 91:4, pages 534-543.
Crossref
Crossref
David C Metz, Guillaume Cadiot, Pierre Poitras, Tetsuhide Ito & Robert T Jensen. (2017) Diagnosis of Zollinger–Ellison syndrome in the era of PPIs, faulty gastrin assays, sensitive imaging and limited access to acid secretory testing. International Journal of Endocrine Oncology 4:4, pages 167-185.
Crossref
Crossref
Davide Campana, Davide Ravizza, Piero Ferolla, Antongiulio Faggiano, Franco Grimaldi, Manuela Albertelli, Claudio Ricci, Donatella Santini, Nicole Brighi, Nicola Fazio, Annamaria Colao, Diego Ferone & Paola Tomassetti. (2016) Risk factors of type 1 gastric neuroendocrine neoplasia
in patients with chronic atrophic gastritis. A retrospective,
multicentre study. Endocrine 56:3, pages 633-638.
Crossref
Crossref
Britney Corey & Herbert Chen. (2017) Neuroendocrine Tumors of the Stomach. Surgical Clinics of North America 97:2, pages 333-343.
Crossref
Crossref
Flavio Curnis, Fabrizio Marcucci, Elisabetta Ferrero & Angelo Corti. 2017. Chromogranins: from Cell Biology to Physiology and Biomedicine. Chromogranins: from Cell Biology to Physiology and Biomedicine
83
98
.
Liv Sagatun, Patricia Mjønes, Constantin S. Jianu, Malcolm Boyce, Hege L. Waldum & Reidar Fossmark. (2016) The gastrin receptor antagonist netazepide (YF476) in patients with type 1 gastric enterochromaffin-like cell neuroendocrine tumours: review of long-term treatment. European Journal of Gastroenterology & Hepatology 28:11, pages 1345-1352.
Crossref
Crossref
C. Castoro, R. Le Moli, M. L. Arpi, M. Tavarelli, G. Sapuppo, L. Frittitta, S. Squatrito & G. Pellegriti. (2016) Association of autoimmune thyroid diseases, chronic atrophic gastritis and gastric carcinoid: experience from a single institution. Journal of Endocrinological Investigation 39:7, pages 779-784.
Crossref
Crossref
Lise Pedersen & Mads Nybo. (2014) Preanalytical factors of importance for measurement of Chromogranin A. Clinica Chimica Acta 436, pages 41-44.
Crossref
Crossref
Johann Guillemot, Marlène Guérin, Erwan Thouënnon, Maité Montéro-Hadjadje, Jérôme Leprince, Hervé Lefebvre, Marc Klein, Mihaela Muresan, Youssef Anouar & Laurent Yon. (2014) Characterization and Plasma Measurement of the WE-14 Peptide in Patients with Pheochromocytoma. PLoS ONE 9:2, pages e88698.
Crossref
Crossref
Argyro Nicolaou, Dimitrios Thomas, Krystallenia I. Alexandraki, Stavros Sougioultzis, Apostolos V. Tsolakis & Gregory Kaltsas. (2014) Predictive Value of Gastrin Levels for the Diagnosis of Gastric Enterochromaffin-Like Cell Hyperplasia in Patients with Hashimoto's Thyroiditis. Neuroendocrinology 99:2, pages 118-122.
Crossref
Crossref
Luca Crippa, Mimma Bianco, Barbara Colombo, Anna M. Gasparri, Elisabetta Ferrero, Y. Peng Loh, Flavio Curnis & Angelo Corti. (2013) A new chromogranin A–dependent angiogenic switch activated by thrombin. Blood 121:2, pages 392-402.
Crossref
Crossref
R. Fiocca, L. Mastracci, S. E. Attwood, C. Ell, J.‐P. Galmiche, J. Hatlebakk, A. Bärthel, G. Långström, T. Lind & L. Lundell. (2012) Gastric exocrine and endocrine cell morphology under prolonged acid inhibition therapy: results of a 5‐year follow‐up in the LOTUS trial. Alimentary Pharmacology & Therapeutics 36:10, pages 959-971.
Crossref
Crossref
Eleonora Dondossola, Anna Maria Gasparri, Barbara Colombo, Angelina Sacchi, Flavio Curnis & Angelo Corti. (2011) Chromogranin A Restricts Drug Penetration and Limits the Ability of NGR-TNF to Enhance Chemotherapeutic Efficacy. Cancer Research 71:17, pages 5881-5890.
Crossref
Crossref
L. Vannella, A. Sbrozzi-Vanni, E. Lahner, C. Bordi, E. Pilozzi, V. D. Corleto, J. F. Osborn, G. Delle Fave & B. Annibale. (2011) Development of type I gastric carcinoid in patients with chronic atrophic gastritis. Alimentary Pharmacology & Therapeutics 33:12, pages 1361-1369.
Crossref
Crossref
Rafael Molina, Elias Alvarez, Angeles Aniel-Quiroga, Maria Borque, Belen Candás, Antonio Leon, Rafael M. Poyatos & Montserrat Gelabert. (2010) Evaluation of chromogranin A determined by three different procedures in patients with benign diseases, neuroendocrine tumors and other malignancies. Tumor Biology 32:1, pages 13-22.
Crossref
Crossref
Jeremiah V. Ojeaburu, Tetsuhide Ito, Pellegrino Crafa, Cesare Bordi & Robert T. Jensen. (2010) Mechanism of Acid Hypersecretion Post Curative Gastrinoma Resection. Digestive Diseases and Sciences 56:1, pages 139-154.
Crossref
Crossref
Giovanni Gori, Giacomo Spinelli, Claudio Spinelli, Marco Tuccori, Corrado Blandizzi & Mario Del Tacca. (2010) Esomeprazole-induced hyperchromograninemia in the absence of concomitant hypergastrinemia. Nature Reviews Gastroenterology & Hepatology 7:11, pages 642-646.
Crossref
Crossref
Marlène Guérin, Johann Guillemot, Erwan Thouënnon, Alice Pierre, Fatima-Zohra El-Yamani, Maité Montero-Hadjadje, Christophe Dubessy, Rabia Magoul, Isabelle Lihrmann, Youssef Anouar & Laurent Yon. (2010) Granins and their derived peptides in normal and tumoral chromaffin tissue: Implications for the diagnosis and prognosis of pheochromocytoma. Regulatory Peptides 165:1, pages 21-29.
Crossref
Crossref
Constantin S. Jianu, Reidar Fossmark, Unni Syversen, Øyvind Hauso & Helge L. Waldum. (2010) A meal test improves the specificity of chromogranin A as a marker of neuroendocrine neoplasia. Tumor Biology 31:5, pages 373-380.
Crossref
Crossref
Z. El Ali, M. Fichna, J. Piniewska, J. Kosowicz & M. Grzymisławski. (2009) Chromogranin A as a useful neuroendocrine marker in patients with autoimmune Addison’s disease. Journal of Endocrinological Investigation 33:3, pages 186-191.
Crossref
Crossref
Kamal A. S. Al-Shoumer & Bagavathy A. Vasanthy. (2009) Serum Chromogranin A Concentration in Hyperthyroidism before and after Medical Treatment. The Journal of Clinical Endocrinology & Metabolism 94:7, pages 2321-2324.
Crossref
Crossref
Istvan Pregun, Peter Gergics, Gabriella Dabasi, Peter Igaz, Karoly Racz & Zsolt Tulassay. (2009) Serum chromogranin A reflects regression of metastatic carcinoid during prolonged octreotide treatment. European Journal of Gastroenterology & Hepatology 21:4, pages 476-477.
Crossref
Crossref
Sirianong Namwongprom, Franklin C. Wong, Ukihide Tateishi, Edmund E. Kim & Sombut Boonyaprapa. (2008) Correlation of chromogranin A levels and somatostatin receptor scintigraphy findings in the evaluation of metastases in carcinoid tumors. Annals of Nuclear Medicine 22:4, pages 237-243.
Crossref
Crossref
Christophe E. M. De Block, Ivo H. De Leeuw & Luc F. Van Gaal. (2008) Autoimmune Gastritis in Type 1 Diabetes: A Clinically Oriented Review. The Journal of Clinical Endocrinology & Metabolism 93:2, pages 363-371.
Crossref
Crossref
É. Baudin, M. Ducreux & M. d’Herbomez. 2008. Tumeurs endocrines thoraciques et digestives. Tumeurs endocrines thoraciques et digestives
29
43
.
B. I. HIRSCHOWITZ, J. WORTHINGTON, J. MOHNEN & M. HABER. (2007) Chromogranin A in patients with acid hypersecretion and/or hypergastrinaemia. Alimentary Pharmacology & Therapeutics 26:6, pages 869-878.
Crossref
Crossref
Vanesa Gregorc, Anna Spreafico, Irene Floriani, Barbara Colombo, Vienna Ludovini, Lorenza Pistola, Guido Bellezza, Maria Grazia Viganò, Eugenio Villa & Angelo Corti. (2007) Prognostic value of circulating chromogranin A and soluble tumor necrosis factor receptors in advanced nonsmall cell lung cancer. Cancer 110:4, pages 845-853.
Crossref
Crossref
Mohammad Fayyaz, Shahid Mehboob, Valerie Andersen & Michael D. Sitrin. (2007) Extended Octreotide Suppression Test to Determine Hormone Responsiveness of Multiple Type I Gastric Carcinoid Tumors. Digestive Diseases and Sciences 52:6, pages 1579-1585.
Crossref
Crossref
Davide Campana, Francesca Nori, Lidya Piscitelli, Antonio Maria Morselli-Labate, Raffaele Pezzilli, Roberto Corinaldesi & Paola Tomassetti. (2007) Chromogranin A: Is It a Useful Marker of Neuroendocrine Tumors?. Journal of Clinical Oncology 25:15, pages 1967-1973.
Crossref
Crossref
Mats Stridsberg, Barbro Eriksson, Bengt Fellström, Gudjon Kristiansson & Eva Tiensuu Janson. (2007) Measurements of chromogranin B can serve as a complement to chromogranin A. Regulatory Peptides 139:1-3, pages 80-83.
Crossref
Crossref
Johann Guillemot, Youssef Anouar, Maïté Montero-Hadjadje, Eric Grouzmann, Luca Grumolato, Joana Roshmaninho-Salgado, Valérie Turquier, Céline Duparc, Hervé Lefebvre, Pierre-François Plouin, Marc Klein, Mihaela Muresan, Billy K.C. Chow, Hubert Vaudry & Laurent Yon. (2006) Circulating EM66 is a highly sensitive marker for the diagnosis and follow-up of pheochromocytoma. International Journal of Cancer 118:8, pages 2003-2012.
Crossref
Crossref
F Tropea, S Baldari, G Restifo, M T Fiorillo, P Surace & A Herberg. (2006) Evaluation of Chromogranin A Expression in Patients with Non-Neuroendocrine Tumours. Clinical Drug Investigation 26:12, pages 715-722.
Crossref
Crossref
Linda C. Samuelson. 2006. Physiology of the Gastrointestinal Tract. Physiology of the Gastrointestinal Tract
1293
1312
.
A. Leon, M. TortaR. Dittadi, E. degli Uberti, M.R. Ambrosio, G. Delle Fave, F. De Braud, P. Tomassetti, M. Gion & L. Dogliotti. (2018) Comparison between Two Methods in the Determination of Circulating Chromogranin A in Neuroendocrine Tumors (NETs): Results of a Prospective Multicenter Observational Study. The International Journal of Biological Markers 20:3, pages 156-168.
Crossref
Crossref
M Peracchi, C Gebbia, G Basilisco, M Quatrini, C Tarantino, C Vescarelli, S Massironi & D Conte. (2005) Plasma chromogranin A in patients with autoimmune chronic atrophic gastritis, enterochromaffin-like cell lesions and gastric carcinoids. European Journal of Endocrinology 152:3, pages 443-448.
Crossref
Crossref
Eiji Nakamura, Takashi Kataoka, Kazuharu Furutani, Keisuke Jimbo, Takeshi Aihara, Satoshi Tanaka, Atsushi Ichikawa, Hiroshi Ohtsu & Susumu Okabe. (2004) Lack of histamine alters gastric mucosal morphology: comparison of histidine decarboxylase-deficient and mast cell-deficient mice. American Journal of Physiology-Gastrointestinal and Liver Physiology 287:5, pages G1053-G1061.
Crossref
Crossref
Lars Kölby, Peter Bernhardt, Christina Swärd, Viktor Johanson, Håkan Ahlman, Eva Forssell-Aronsson, Mats Stridsberg, Bo Wängberg & Ola Nilsson. (2004) Chromogranin A as a determinant of midgut carcinoid tumour volume. Regulatory Peptides 120:1-3, pages 269-273.
Crossref
Crossref
Christophe E.M. De Block, Gert Colpin, Kristof Thielemans, Willy Coopmans, Johannes J.P.M. Bogers, Paul A. Pelckmans, Eric A.E. Van Marck, Viviane Van Hoof, Manou Martin, Ivo H. De Leeuw, Roger Bouillon & Luc F. Van Gaal. (2004) Neuroendocrine Tumor Markers and Enterochromaffin-Like Cell Hyper/Dysplasia in Type 1 Diabetes. Diabetes Care 27:6, pages 1387-1393.
Crossref
Crossref
Masahiro Ono, Hiroshi Sato, Hideaki Kazumori, Mika Yuki, Mohammad Azharul Karim Rumi, Cesar Francisco Ortega-Cava, Yasunobu Ishihara, Shunji Ishihara, Kyoichi Adachi & Yoshikazu Kinoshita. (2003) Effect of a gastrin/cholecystokinin B receptor antagonist, S-0509, on the omeprazole-induced proliferation of gastric mucosa in rats. Journal of Laboratory and Clinical Medicine 142:6, pages 364-371.
Crossref
Crossref
Irvin M. Modlin, Kevin D. Lye & Mark Kidd. (2003) Carcinoid tumors of the stomach. Surgical Oncology 12:2, pages 153-172.
Crossref
Crossref
Linda C. SamuelsonKaren L. Hinkle. (2003) Insights into the Regulation of Gastric Acid Secretion Through Analysis of Genetically Engineered Mice. Annual Review of Physiology 65:1, pages 383-400.
Crossref
Crossref
Paolo L. Peghini, Bruno Annibale, Cinzia Azzoni, Massimo Milione, Vito D. Corleto, Fathia Gibril, David J. Venzon, Gianfranco Delle Fave, Cesare Bordi & Robert T. Jensen. (2002) Effect of chronic hypergastrinemia on human enterochromaffin-like cells: Insights from patients with sporadic gastrinomas. Gastroenterology 123:1, pages 68-85.
Crossref
Crossref
S. Bashir, F. Gibril, J. V. Ojeaburu, B. Asgharian, L. K. Entsuah, G. Ferraro, P. Crafa, C. Bordi & R. T. Jensen. (2002) Prospective study of the ability of histamine, serotonin or serum chromogranin A levels to identify gastric carcinoids in patients with gastrinomas. Alimentary Pharmacology & Therapeutics 16:7, pages 1367-1382.
Crossref
Crossref
Erik Mårdh, Sven Mårdh, Bibbi Mårdh & Kurt Borch. (2002) Diagnosis of gastritis by means of a combination of serological analyses. Clinica Chimica Acta 320:1-2, pages 17-27.
Crossref
Crossref
S. Sanduleanu, A. De Bruïne, M. Stridsberg, D. Jonkers, I. Biemond, W. Hameeteman, G. Lundqvist & R. W. Stockbrügger. (2001) Serum chromogranin A as a screening test for gastric enterochromaffin‐like cell hyperplasia during acid‐suppressive therapy. European Journal of Clinical Investigation 31:9, pages 802-811.
Crossref
Crossref
M. Sagar, L. Bertilsson, M. Stridsberg, A. Kjellin, S. Mårdh & R. Seensalu. (2001) Omeprazole and CYP2C19 polymorphism: effects of long‐term treatment on gastrin, pepsinogen I, and chromogranin A in patients with acid related disorders. Alimentary Pharmacology & Therapeutics 14:11, pages 1495-1502.
Crossref
Crossref
Th�r�se Lehy, Anne-Marie Roucayrol & Michel Mignon. (2000) Histomorphological characteristics of gastric mucosa in patients with Zollinger-Ellison syndrome or autoimmune gastric atrophy: Role of gastrin and atrophying gastritis. Microscopy Research and Technique 48:6, pages 327-338.
Crossref
Crossref
U.-F. Pape, M. Höcker, U. Seuß & B. Wiedenmann. 2000. Peptides in Oncology III. Peptides in Oncology III
45
60
.
Stephan U. Goebel, Jose Serrano, Fang Yu, Fathia Gibril, David J. Venzon & Robert T. Jensen. (1999) Prospective study of the value of serum chromogranin A or serum gastrin levels in the assessment of the presence, extent, or growth of gastrinomas. Cancer 85:7, pages 1470-1483.
Crossref
Crossref
Sanduleanu, Stridsberg, Jonkers, Hameeteman, Biemond, Lundqvist, Lamers & Stockbrügger. (1999) Serum gastrin and chromogranin A during medium- and long-term acid suppressive therapy: a case-control study. Alimentary Pharmacology & Therapeutics 13:2, pages 145-153.
Crossref
Crossref